SMOC1 and Alzheimer disease: These findings suggest that type I interferon signaling represents a robust candidate for the mechanism of cognitive impairment in the post-COVID spectrum and that it may contribute to glial-driven neuroinflammation in the setting of Alzheimer’s disease via dysregulated IFITM and OAS family genes and impaired cognitive resilience mechanisms.